SCARB2 and hepatocellular carcinoma: Similar to SCARB2 deletion, PMB treatment suppressed the proliferation of several HCC cell lines, and the combination of PMB with sorafenib showed a synergistic effect on HCC cells (Supplementary Fig. 5d).